Genre
ReviewJournal
Date
2019-10-01Author
Giordano, ATommonaro, G
Permanent link to this record
http://hdl.handle.net/20.500.12613/4304
Metadata
Show full item recordDOI
10.3390/nu11102376Abstract
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. Curcumin, a polyphenol extracted from Curcuma longa in 1815, has gained attention from scientists worldwide for its biological activities (e.g., antioxidant, anti-inflammatory, antimicrobial, antiviral), among which its anticancer potential has been the most described and still remains under investigation. The present review focuses on the cell signaling pathways involved in cancer development and proliferation, and which are targeted by curcumin. Curcumin has been reported to modulate growth factors, enzymes, transcription factors, kinase, inflammatory cytokines, and proapoptotic (by upregulation) and antiapoptotic (by downregulation) proteins. This polyphenol compound, alone or combined with other agents, could represent an effective drug for cancer therapy.Citation to related work
MDPI AGHas part
NutrientsADA compliance
For Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.eduae974a485f413a2113503eed53cd6c53
http://dx.doi.org/10.34944/dspace/4286